The apolipoprotein B Q3405E polymorphism has no effect on its low-density-lipoprotein receptor binding affinity

Human Genetics

Volumn 98, Issue 6, 1996, Pages 678-680

  Pullinger, Clive R ^a   Love, Janette A ^a   Liu, Weiqun ^a   Hennessy, Lori K ^a   Ghassemzadeh, Marjan ^a   Newcomb, Kenneth C ^c   Illingworth, D Roger ^c   Kane, John P ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; DNA; GLUTAMIC ACID; LOW DENSITY LIPOPROTEIN RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; FIBROBLAST; GENE FREQUENCY; HETEROZYGOTE; HUMAN; NORMAL HUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ALLELES; APOLIPOPROTEINS B; BINDING, COMPETITIVE; GLUTAMIC ACID; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, LDL;

EID: 0029958103     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050283     Document Type: Article

References (12)

1. Dunning AM, Houlston R, Frostegard J, Revill J, Nilsson J, Hamsten A, Talmud P, Humphries S (1991) Genetic evidence that the putative receptor binding domain of apolipoprotein B (residues 3130 to 3630) is not the only region of the protein involved in interaction with the low density lipoprotein receptor. Biochim Biophys Acta 1096:231-237
2. Goldstein JL, Basu SK, Brown MS (1983) Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 98:241-260
3. Goldstein JL, Hobbs HH, Brown MS (1995) Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill, New York, pp 1981-2030
4. Knott TJ, Wallis SC, Powell LM, Pease RJ, Lusis AJ, Blackhart B, McCarthy BJ, Mahley RW, Levy-Wilson B, Scott J (1986) Complete cDNA and derived protein sequence of human apolipoprotein B-100. Nucleic Acids Res 14:7501-7503
5. Ludwig EH, Blackhart BD, Pierotti VR, Caiati L, Fortier C, Knott T, Scott J, Mahley RW, Levy-Wilson B, McCarthy BJ (1987) DNA sequence of the human apolipoprotein B gene. DNA 6:363-372
6. Mendel CM (1994) A novel assay for comparing affinity constants of ligands with small differences in affinity: application to low-density lipoproteins. Anal Biochem 216:328-334
7. Pease RJ, Milne RW, Jessup WK, Law A, Provost P, Fruchart J-C, Dean RT, Marcel YL, Scott J (1990) Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100. J Biol Chem 265:553-568
8. Pullinger CR, Zysow BR, Hennessy LK, Frost PH, Malloy MJ, Kane JP (1993) Molecular cloning and characteristics of a new apolipoprotein-C-II mutant identified in 3 unrelated individuals with hypercholesterolemia and hypertriglyceridemia. Hum Mol Genet 2:69-74.
9. Pullinger CR, Hennessy LK, Chatterton JE, Liu WQ, Love JA, Mendel CM, Frost PH, Malloy MJ, Schumaker VN, Kane JP (1995) Familial ligand-defective apolipoprotein B: identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest 95:1225-1234
10. Yang C -Y, Chen S-H, Gianturco SH, Bradley WA, Sparrow JT, Tanimura M, Li W-H, Sparrow DA, DeLoof H, Rosseneu M, Lee F-S, Gu Z-W, Gotto AM Jr, Chan L (1986) Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100. Nature 323:738-742
11. Yang C-Y, Gu Z-W, Weng S-A, Kim TW, Chen S-H, Pownall HJ, Sharp PM, Liu S-W, Li W-H, Gotto AM Jr, Chan L (1989) Structure of apolipoprotein B-100 human low density lipoproteins. Arteriosclerosis 9:96-108
12. Zysow BR, Pullinger CR, Hennessy LK, Farese RV, Ghassemzadeh M, Kane JP (1994) The apolipoprotein C-II variant apoC-H(Lysl9→Thr) is not associated with dyslipidemia in an affected kindred. Clin Genet 45:292-297